AI Science Tracker
EN

Lyda Hill Department of Bioinformatics

1 discovery from 2021

Discoveries

Patterns of Pretreatment Reward Task Brain Activation Predict Individual Antidepressant Response: Key Results From the EMBARC Randomized Clinical Trial.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Specific clinical reference validation of later symptom outcomes using learned imaging/clinical predictors; narrower sertraline result avoids duplicating earlier bupropion work and avoids attributing modeled NNT to observed clinical benefit.

Technology: Specific clinical reference validation of later symptom outcomes using learned imaging/clinical predictors; narrower sertraline result avoids duplicating earlier bupropion work and avoids attributing modeled NNT to observed clinical benefit.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Specific clinical reference validation of later symptom outcomes using learned imaging/clinical predictors; narrower sertraline result avoids duplicating earlier bupropion work and avoids attributing modeled NNT to observed clinical benefit.
Limitation / still unknown
Full text reports the relevant cohort/measure, comparison or reference, and evaluation supporting this bounded claim.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC8857018/ · https://pubmed.ncbi.nlm.nih.gov/34916068/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.